Cargando…

Efficacy and safety of repaglinide vs nateglinide for treatment of Japanese patients with type 2 diabetes mellitus

Aims/Introduction: Repaglinide is a short‐acting insulin secretagogue. We assessed the efficacy and safety of repaglinide in comparison with nateglinide in Japanese patients with type 2 diabetes previously treated with diet and exercise. Materials and Methods: In this 16‐week randomized, multicent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawamori, Ryuzo, Kaku, Kohei, Hanafusa, Toshiaki, Kashiwabara, Daisuke, Kageyama, Shigeru, Hotta, Nigishi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014954/ https://www.ncbi.nlm.nih.gov/pubmed/24843581 http://dx.doi.org/10.1111/j.2040-1124.2011.00188.x

Ejemplares similares

Effect of combination therapy with repaglinide and metformin hydrochloride on glycemic control in Japanese patients with type 2 diabetes mellitus
por: Kawamori, Ryuzo, et al.
Publicado: (2014)

Clinical study of repaglinide efficacy and safety in type 2 diabetes mellitus patients with blood glucose levels inadequately controlled by sitagliptin
por: Kawamori, Ryuzo, et al.
Publicado: (2015)

The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus
por: Guardado-Mendoza, Rodolfo, et al.
Publicado: (2013)

Glucose-dependent and Glucose-sensitizing Insulinotropic Effect of Nateglinide: Comparison to Sulfonylureas and Repaglinide
por: Hu, Shiling, et al.
Publicado: (2001)

Characterization of binding by repaglinide and nateglinide with glycated human serum albumin using high‐performance affinity microcolumns
por: Ovbude, Susan T., et al.
Publicado: (2022)

Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: Results from a randomized, 52‐week, open‐label study
por: Yasuda, Hitoshi, et al.
Publicado: (2015)

Repaglinide, but Not Nateglinide Administered Supraspinally and Spinally Exerts an Anti-Diabetic Action in D-Glucose Fed and Streptozotocin-Treated Mouse Models
por: Sim, Yun-Beom, et al.
Publicado: (2013)

Superiority of duloxetine to placebo in improving diabetic neuropathic pain: Results of a randomized controlled trial in Japan
por: Yasuda, Hitoshi, et al.
Publicado: (2011)

Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide
por: Kudo‐Fujimaki, Kyoko, et al.
Publicado: (2013)

Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study
por: Kawamori, Ryuzo, et al.
Publicado: (2013)

Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes
por: Israel, Marc K, et al.
Publicado: (2008)

Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea
por: Omori, Kazuno, et al.
Publicado: (2018)

Comparison of sitagliptin with nateglinide on postprandial glucose and related hormones in drug-naïve Japanese patients with type 2 diabetes mellitus: A pilot study
por: Tanimoto, Masumi, et al.
Publicado: (2015)

Helical‐Like Assembly of Nateglinide as Coating for Oral Delivery of Insulin and Their Synergistic Prevention of Diabetes Mellitus
por: Li, Yanfei, et al.
Publicado: (2023)

Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus
por: Xie, Jing, et al.
Publicado: (2019)

Sodium intake in men and potassium intake in women determine the prevalence of metabolic syndrome in Japanese hypertensive patients: OMEGA Study
por: Teramoto, Tamio, et al.
Publicado: (2011)

Repaglinide-Induced Acute Pancreatitis
por: Udongwo, Ndausung, et al.
Publicado: (2021)

Safety, efficacy, and early clinical experience of insulin degludec in Japanese people with diabetes mellitus: A first-year report from Japan
por: Kaku, Kohei, et al.
Publicado: (2015)

Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports
por: Razzaghy-Azar, Maryam, et al.
Publicado: (2021)

A review of nateglinide in the management of patients with type 2 diabetes
por: Tentolouris, Nicholas, et al.
Publicado: (2007)

Development and validation of analytical method for the estimation of nateglinide in rabbit plasma
por: Pani, Nihar Ranjan, et al.
Publicado: (2012)

Does the treatment of type 2 diabetes mellitus with the DPP-4 inhibitor vildagliptin reduce HbA1c to a greater extent in Japanese patients than in Caucasian patients?
por: Foley, James E, et al.
Publicado: (2016)

Nateglinide is Effective for Diabetes Mellitus with Reactive Hypoglycemia in a Child with a Compound Heterozygous ABCC8 Mutation
por: Saito-Hakoda, Akiko, et al.
Publicado: (2012)

Formulation and Evaluation of Transdermal Patch of Repaglinide
por: Prajapati, Shailesh T., et al.
Publicado: (2011)

Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New-Onset Type 2 Diabetes Mellitus
por: Younas, Amna, et al.
Publicado: (2021)

Effects of Glucose Load and Nateglinide Intervention on Endothelial Function and Oxidative Stress
por: Wang, Leilei, et al.
Publicado: (2013)

Long‐term efficacy and safety of canagliflozin in combination with insulin in Japanese patients with type 2 diabetes mellitus
por: Inagaki, Nobuya, et al.
Publicado: (2017)

Efficacy and safety of ipragliflozin add‐on therapy to insulin in Japanese patients with type 1 diabetes mellitus: A randomized, double‐blind, phase 3 trial
por: Kaku, Kohei, et al.
Publicado: (2019)

A Single Nucleotide Polymorphism within DUSP9 Is Associated with Susceptibility to Type 2 Diabetes in a Japanese Population
por: Fukuda, Hisashi, et al.
Publicado: (2012)

Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China
por: Ma, J., et al.
Publicado: (2014)

Replication Study for the Association of 9 East Asian GWAS-Derived Loci with Susceptibility to Type 2 Diabetes in a Japanese Population
por: Sakai, Kensuke, et al.
Publicado: (2013)

Replication study for the association of rs391300 in SRR and rs17584499 in PTPRD with susceptibility to type 2 diabetes in a Japanese population
por: Imamura, Minako, et al.
Publicado: (2012)

Combination therapy of miglitol and insulin in type 1 diabetes mellitus patients
por: Kubo, Sayaka, et al.
Publicado: (2010)

Efficacy and safety of luseogliflozin added to various oral antidiabetic drugs in Japanese patients with type 2 diabetes mellitus
por: Seino, Yutaka, et al.
Publicado: (2015)

Characteristic changes in plasma glutamate levels and free amino acid profiles in Japanese patients with type 1 diabetes mellitus
por: Kawamori, Dan, et al.
Publicado: (2022)

We have become an Open Access journal!
por: Hotta, Nigishi
Publicado: (2014)

Is there a place for inhibition of transforming growth factor‐β and the polyol pathway in therapy for diabetic retinopathy?
por: Hotta, Nigishi
Publicado: (2010)

Why do we need a new journal now?
por: Hotta, Nigishi
Publicado: (2010)

Brave new world: Our journal has become an Open Access journal
por: Hotta, Nigishi
Publicado: (2015)

Like a snail, our journal (JDI) makes slow, but steady, progress
por: Hotta, Nigishi
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ks4e7v43nv2tlf3sqh6vcg9mic